Barclays’s IVERIC bio ISEE Stock Holding History
Bought
Maintained
Sold
Barclays's ISEE Position: Q3 2023 in Review
Barclays sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 235,648 shares — an estimated $9.27M sold.
Barclays first reported a position in ISEE in Q4 2013 and held it in 33 quarters. The position peaked at $17.5M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Barclays reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
- Barclays sold 235,648 IVERIC bio shares in Q3 2023, an estimated $9.27M.
- Barclays first reported a position in IVERIC bio in Q4 2013 and held it in 33 quarters.
- Barclays's IVERIC bio position peaked at $17.5M in Q1 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.